Sign In
Buy ISRG
$350.06
-3.11 (-0.88%)
At Close: Jul 21, 2026
Prediction: These 2 Growth Stocks Will Beat the Market Through 2031
08:15pm, Wednesday, 31'st Dec 2025
Several factors could help Intuitive Surgical's stock soar through 2031, despite recent challenges. Meta Platforms' results might justify its AI investments.
Where Will Intuitive Surgical Be in 5 Years?
04:30pm, Wednesday, 31'st Dec 2025
Intuitive Surgical is a leader in the field of surgical robotics. The company has 10,763 surgical robots in place worldwide.
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
08:35am, Wednesday, 31'st Dec 2025
ISRG's single-port platform posts 91% procedure growth, led by Korea, with U.S. momentum building as new tools and indications expand adoption.
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI
08:26am, Monday, 29'th Dec 2025
VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.
E. Ohman J or Asset Management AB Has $12.66 Million Position in Intuitive Surgical, Inc. $ISRG
05:48am, Sunday, 28'th Dec 2025
E. Ohman J or Asset Management AB raised its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 4.1% during the undefined quarter, according to the company in its most recent 13F filing with the SEC.
Bellecapital International Ltd. Purchases 2,874 Shares of Intuitive Surgical, Inc. $ISRG
05:09am, Sunday, 28'th Dec 2025
Bellecapital International Ltd. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 113.3% in the undefined quarter, according to the company in its most recent Form 13F filing
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now
01:15pm, Saturday, 27'th Dec 2025
These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery.
Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade
05:00am, Saturday, 27'th Dec 2025
Intuitive Surgical is a first-to-market leader in the field of surgical robotics. Medtronic is making headway with its own robot-assisted surgical system.
Is ISRG's 20% Procedure Growth the New Normal or a Peak?
08:21am, Friday, 26'th Dec 2025
ISRG posts 20% Q3 procedure growth as da Vinci and Ion volumes accelerate, but investors question if product cycles and timing effects can sustain it.
Brookstone Capital Management Boosts Stake in Intuitive Surgical, Inc. $ISRG
04:31am, Thursday, 25'th Dec 2025
Brookstone Capital Management increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
10:31am, Wednesday, 24'th Dec 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?
08:06am, Wednesday, 24'th Dec 2025
Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today.
Global X Japan Co. Ltd. Has $17.90 Million Stock Position in Intuitive Surgical, Inc. $ISRG
05:16am, Wednesday, 24'th Dec 2025
Global X Japan Co. Ltd. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 6.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securit
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
10:00am, Tuesday, 23'rd Dec 2025
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
12:11pm, Monday, 22'nd Dec 2025
Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
